P085 Investigating time between annual review encounters in the UK Cystic Fibrosis Registry

McClenaghan, Elliot; Cosgriff, Rebecca; Yip, May; Charman, Susan C.; Lee, A.; Gunn, E.; Earlam, Karen

doi:10.1016/s1569-1993(19)30379-0

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our findings in the Copenhagen CF population, where 91% of patients with relevant infections reported use of inhaled antibiotics within the last 12 months, are similar to results from the UK 19 and the USA, 20 probably representing the realistic upper limit. Regular on/off‐patterns were not reported by any of our participants despite widespread use of tobramycin and aztreonam.…”

Section: Discussionsupporting

confidence: 86%

Use of inhaled antibiotics among Danish patients with cystic fibrosis

Møller¹,

Nielsen²,

Faurholt‐Jepsen³

et al. 2022

Pediatric Pulmonology

View full text Add to dashboard Cite

Background: Inhaled antibiotics are an important part of cystic fibrosis (CF) airway disease management and should be individualized to fit the microorganism and match patient needs. To investigate the implementation of personalized treatment, this study mapped the use of different types of inhaled antibiotics and adherence patterns. Methods: We performed individual structured interviews in a cross-sectional study at the CF Centre in Copenhagen, Denmark. Patients with CF older than 15 years attending clinical consultations were included. Clinical data were obtained from centralized databases.Results: Among 149 participants, 107 (72%) had indication for treatment with inhaled antibiotics. In this group, 97 (91%) reported the use of inhaled antibiotics within the last 12 months. Change from one inhaled antibiotic to another during that period was reported by 31 (29%), and 17 (25%) with Pseudomonas aeruginosa had used off-label antibiotics. Adherence to a minimum of one daily dose of antibiotic was reported by 78%, while adherence to all daily doses was 28 percentage points lower. Skipping inhalations was due to side effects and doubt about the effect in less than 5% of cases. Conclusion:Change of inhaled antibiotics and use of off-label antibiotics for inhalation were common and side effects were a rare cause of nonadherence. This suggests satisfactory implementation of the principle of tailored antibiotic inhalation prescription in the Copenhagen CF population. Adherence to at least one daily inhalation dose was markedly higher than adherence to multiple daily inhalations.

show abstract

Section: Discussionsupporting

confidence: 86%